Chapters

Transcript

Video

Clinical Trial Spotlight: Venetoclax plus Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL)

Dr. Marlise Luskin, a specialist in the Adult Leukemia Program at Dana-Farber Cancer Institute, explains an innovative trial that combines the BCL2 inhibitor, venetoclax with chemotherapy for older patients with ALL. For more information about this trial, visit: https://www.dana-farber.org/clinical-trials2/detail/16-648/


Published

October 4, 2021

Created by

Dana-Farber

Related Presenters

Marlise Luskin, MD, MSCE

Marlise Luskin, MD, MSCE

Assistant Professor of Medicine, Harvard Medical School

Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009.

View full profile